MORF - Eli Lilly to acquire Morphic for $57 a share in cash
2024-07-08 07:05:08 ET
In a bid to strengthen its immunology pipeline, Eli Lilly ( NYSE: LLY ) on Monday announced a deal to acquire biopharmaceutical company Morphic Holding ( NASDAQ: MORF ) for $57 a share in cash, or an aggregate of ~$3.2B, payable at closing....
Eli Lilly to acquire Morphic for $57 a share in cash